MIAMI, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTCPink:EHVVF) (the “Company”), a leading healthcare services and technology company, announced today that its wholly-owned subsidiary, KetaDASH, commenced clinical operations, offering in-home ketamine therapy to patients suffering from treatment-resistant mental health issues. Initially, the treatment will be offered in the San Francisco Bay Area and Greater Sacramento Area with plans to expand to other markets in the coming months. KetaDASH is a managed service organization focused on the psychedelic mental health sector with the mission of helping physicians streamline their practice operations, create new revenue opportunities, and achieve better patient outcomes.
Read more at globenewswire.comEhave, Inc. Launches KetaDASH, Its In-Home Ketamine Therapy In The San Francisco And Sacramento Market
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
